Researchers identify two risk factors that indicate higher risk of aggressive prostate cancer

FHS
July 11, 2024
12:31 pm

A recent European Urology Oncology study assessed the mortality risks, based on the Gleason score and clinical parameters, in patients with prostate cancer.

Does a high-dose influenza vaccine reduce cardiovascular disease risk?

Whether a high-dose influenza vaccine is associated with a benefit in reducing CP events.

September 19, 2023

Senator alleges GSK is shirking its commitment to lower inhaler costs

Sen. Maggie Hassan (D-NH) is pressuring GSK to put a commonly used pediatric inhaler back on the market after the company stopped producing it in

May 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Researchers identify two risk factors that indicate higher risk of aggressive prostate cancer

Does a high-dose influenza vaccine reduce cardiovascular disease risk?

New technology to capture and release cfDNA on nanowire surfaces from urine

Senator alleges GSK is shirking its commitment to lower inhaler costs

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe